Davide Tassinari

Summary

Affiliation: City Hospital
Country: Italy

Publications

  1. ncbi request reprint The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy
    Davide Tassinari
    Department of Oncology, City Hospital, Rimini, Italy
    Support Care Cancer 16:359-70. 2008
  2. ncbi request reprint Quality of life at the end of life: how is the solution far away?
    Davide Tassinari
    J Clin Oncol 20:1704-5. 2002
  3. doi request reprint Transdermal opioids as front line treatment of moderate to severe cancer pain: a systemic review
    Davide Tassinari
    Department of Oncology, City Hospital, Rimini, Italy
    Palliat Med 25:478-87. 2011
  4. doi request reprint Noninferiority trials in second-line treatments of nonsmall cell lung cancer: a systematic review of literature with meta-analysis of phase III randomized clinical trials
    Davide Tassinari
    Department of Oncology, City Hospital, Rimini, Italy
    Am J Clin Oncol 35:593-9. 2012
  5. ncbi request reprint Efficacy of two different platinum- or anthracycline-containing chemotherapy regimens for the treatment of small cell lung cancer
    D Tassinari
    Department of Oncology, City Hospital, viale Settembrini n 2, 47900, Rimini, Italy
    J Chemother 17:228-36. 2005
  6. ncbi request reprint [Chemotherapy in extended small-cell lung cancer. Retrospective analysis of two different series of patients treated with carboplatin and etoposide or ciclophosphamide-epidoxorubicin and etoposide]
    Davide Tassinari
    Divisione di Oncologia, Ospedale Civile Infermi, Rimini
    Recenti Prog Med 96:234-9. 2005
  7. doi request reprint Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: a meta-analysis and systematic review of the literature
    Davide Tassinari
    Department of Oncology, Supportive and Palliatice Care Unit, City Hospital, Rimini, Italy
    J Palliat Med 11:492-501. 2008
  8. ncbi request reprint [Future aims for palliative care]
    Davide Tassinari
    Modulo di Terapie di Supporto e Palliative, Divisione di Oncologia, Ospedale Civile degli Infermi, Rimini
    Recenti Prog Med 97:571-9. 2006
  9. ncbi request reprint Zoledronic acid treatment at home: safety data from an observational prospective trial
    Davide Tassinari
    Department of Oncology, City Hospital, Rimini, Italy
    J Palliat Med 10:352-8. 2007
  10. ncbi request reprint Disseminated intravascular coagulation during treatment with thalidomide. A case report
    Davide Tassinari
    Department of Oncology, City Hospital, Rimini, Italy
    Tumori 94:746-7. 2008

Detail Information

Publications48

  1. ncbi request reprint The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy
    Davide Tassinari
    Department of Oncology, City Hospital, Rimini, Italy
    Support Care Cancer 16:359-70. 2008
    ..To evaluate the accuracy of the Palliative Prognostic Score (PaP score) in selecting metastatic gastrointestinal or nonsmall-cell lung cancer patients candidate to palliative chemotherapy...
  2. ncbi request reprint Quality of life at the end of life: how is the solution far away?
    Davide Tassinari
    J Clin Oncol 20:1704-5. 2002
  3. doi request reprint Transdermal opioids as front line treatment of moderate to severe cancer pain: a systemic review
    Davide Tassinari
    Department of Oncology, City Hospital, Rimini, Italy
    Palliat Med 25:478-87. 2011
    ..To assess the role of transdermal opioids as a front-line approach to moderate to severe cancer pain...
  4. doi request reprint Noninferiority trials in second-line treatments of nonsmall cell lung cancer: a systematic review of literature with meta-analysis of phase III randomized clinical trials
    Davide Tassinari
    Department of Oncology, City Hospital, Rimini, Italy
    Am J Clin Oncol 35:593-9. 2012
    ..To assess the role of the novel second-line treatments in nonsmall cell lung cancer (NSCLC)...
  5. ncbi request reprint Efficacy of two different platinum- or anthracycline-containing chemotherapy regimens for the treatment of small cell lung cancer
    D Tassinari
    Department of Oncology, City Hospital, viale Settembrini n 2, 47900, Rimini, Italy
    J Chemother 17:228-36. 2005
    ..02). No difference in side effects was observed between the two groups of patients. Our data suggest a role for anthracycline-containing regimens as first-line treatment of small cell lung cancer...
  6. ncbi request reprint [Chemotherapy in extended small-cell lung cancer. Retrospective analysis of two different series of patients treated with carboplatin and etoposide or ciclophosphamide-epidoxorubicin and etoposide]
    Davide Tassinari
    Divisione di Oncologia, Ospedale Civile Infermi, Rimini
    Recenti Prog Med 96:234-9. 2005
    ....
  7. doi request reprint Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: a meta-analysis and systematic review of the literature
    Davide Tassinari
    Department of Oncology, Supportive and Palliatice Care Unit, City Hospital, Rimini, Italy
    J Palliat Med 11:492-501. 2008
    ..To assess the adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison with slow release oral morphine...
  8. ncbi request reprint [Future aims for palliative care]
    Davide Tassinari
    Modulo di Terapie di Supporto e Palliative, Divisione di Oncologia, Ospedale Civile degli Infermi, Rimini
    Recenti Prog Med 97:571-9. 2006
    ..Nevertheless, all the efforts to improve the quality of clinical research in palliative care will have to be focused on protocols of global interventions...
  9. ncbi request reprint Zoledronic acid treatment at home: safety data from an observational prospective trial
    Davide Tassinari
    Department of Oncology, City Hospital, Rimini, Italy
    J Palliat Med 10:352-8. 2007
    ..To prospectively assess feasibility, side effects, and safety of a home treatment with zoledronic acid in patients with bone metastases confined to home...
  10. ncbi request reprint Disseminated intravascular coagulation during treatment with thalidomide. A case report
    Davide Tassinari
    Department of Oncology, City Hospital, Rimini, Italy
    Tumori 94:746-7. 2008
    ....
  11. ncbi request reprint Second line treatments in advanced platinum-resistant non small cell lung cancer. A critical review of literature
    Davide Tassinari
    Department of Oncology, City Hospital, Rimini, Italy
    Rev Recent Clin Trials 4:27-33. 2009
    ....
  12. doi request reprint Second-line treatments in non-small cell lung cancer. A systematic review of literature and metaanalysis of randomized clinical trials
    Davide Tassinari
    City Hospital, Department of Oncology, Via Settembrini 2, Rimini 47900, Italy
    Chest 135:1596-609. 2009
    ..To assess the efficacy of second-line treatments in non-small cell lung cancer (NSCLC)...
  13. ncbi request reprint [Role of sequential chemotherapy in the treatment of metastatic colorectal cancer]
    Davide Tassinari
    Modulo di Terapie di Supporto e Palliative, Ospedale Civile Infermi, Rimini
    Recenti Prog Med 100:73-9. 2009
    ..Aim of our work was to assess the role of prognostic and predictive factors in patients to be treated with II and III line chemotherapy in metastatic colorectal cancer...
  14. ncbi request reprint [Transdermal opiates in the treatment of moderate-severe cancer pain. Recommendations for clinical practice]
    Davide Tassinari
    Modulo di Terapie di Supporto e Palliative, Ospedale Civile Infermi, Rimini
    Recenti Prog Med 100:551-8. 2009
    ..Transdermal opiates represent a safety and effective alternative to oral morphine against cancer pain, but they can not replace oral morphine as the gold standard first-line treatment of moderate-severe cancer pain...
  15. doi request reprint [Neuropathic pain in oncology. Novel evidence for clinical practice]
    Davide Tassinari
    Modulo di Terapie di Supporto e Palliative, Ospedale Civile Infermi, Rimini
    Recenti Prog Med 102:220-7. 2011
    ..Further trials comparing the different effective options are needed to better define the correct approach against neuropathic pain in oncology...
  16. doi request reprint The second step of the analgesic ladder and oral tramadol in the treatment of mild to moderate cancer pain: a systematic review
    Davide Tassinari
    Department of Oncology, City Hospital, Italy
    Palliat Med 25:410-23. 2011
    ..To analyse the evidence supporting the widespread use of modified analgesic ladders or oral tramadol as alternatives to codeine/paracetamol for mild to moderate cancer pain...
  17. doi request reprint Bevacizumab in the treatment of advanced, non-squamous non-small cell lung cancer: an evidence-based approach
    Davide Tassinari
    Department of Oncology, City Hospital, Rimini, Italy
    Oncology 80:350-8. 2011
    ....
  18. ncbi request reprint Outcome research in palliative care: could it represent a new dimension of clinical research or clinical practice?
    Davide Tassinari
    Department of Oncology, City Hospital, Rimini, Italy
    Support Care Cancer 13:176-81. 2005
    ..The models of the different designs of pharmacoeconomic analysis are revisited in an attempt to conjugate the pharmacoeconomic evaluation with the particular dimension of palliative care...
  19. pmc Surrogate end points of quality of life assessment: have we really found what we are looking for?
    Davide Tassinari
    Department of Oncology, City Hospital, viale Settembrini, 47900, Rimini, Italy
    Health Qual Life Outcomes 1:71. 2003
    ..A correct use of surrogate end points of quality of life within and not instead of quality of life assessment should be the engagement of our further efforts in quality of life research...
  20. ncbi request reprint [Subacute cerebellar degeneration and pleural mesothelioma. Report of a case]
    D Tassinari
    Divisione di Oncologia, Ospedale Civile, Rimini
    Recenti Prog Med 91:301-2. 2000
    ..In our report it can be supposed that an aberrant production of cytokines might have triggered an autoimmune reaction, causing anti Purkinje cells antibodies production, neurological damage and clinical outcome...
  21. ncbi request reprint Carboplatin and gemcitabine in the palliative treatment of stage IV non-small cell lung cancer: definitive results of a phase II trial
    Davide Tassinari
    Department of Oncology, City Hospital, Rimini, Italy
    Tumori 90:54-9. 2004
    ..In this phase II trial, we evaluated the activity and safety of a schedule with carboplatin and gemcitabine, defined in our previous phase I trial...
  22. ncbi request reprint Combination chemotherapy of carboplatin and gemcitabine against solid tumors: a phase I trial
    D Tassinari
    Department of Oncology, City Hospital, Rimini, Italy
    Int J Clin Oncol 6:279-83. 2001
    ..The present phase I trial was planned to define the maximum tolerated dose and the dose-limiting toxicity of a carboplatin-gemcitabine combination...
  23. ncbi request reprint Bolus fluorouracil and leucovorin with oxaliplatin as first-line treatment in metastatic colorectal cancer
    Alberto Ravaioli
    Department of Oncology, Infermi Hospital, Via Settembrini 2, 47900 Rimini, Italy
    J Clin Oncol 20:2545-50. 2002
    ..A phase II trial investigated the activity and toxicity of a bolus administration schedule of oxaliplatin, fluorouracil (5-FU), and leucovorin (LV) therapy in patients with untreated advanced colorectal cancer...
  24. ncbi request reprint Transdermal fentanyl as a front-line approach to moderate-severe pain: a meta-analysis of randomized clinical trials
    Davide Tassinari
    Supportive and Palliative Care Unit, Department of Oncology, City Hospital, Rimini, Italy
    J Palliat Care 25:172-80. 2009
    ..The safety of transdermal fentanyl (TF) in comparison with slow-release oral morphine (SROM) in moderate-severe pain was assessed...
  25. ncbi request reprint Rapid progression of advanced "hormone-resistant" prostate cancer during palliative treatment with progestins for cancer cachexia
    Davide Tassinari
    Department of Oncology, City Hospital, Rimini, Italy
    J Pain Symptom Manage 25:481-4. 2003
    ....
  26. doi request reprint [Radically resected pancreatic cancer and adjuvant treatment. A review of the literature]
    Fabrizio Drudi
    Ospedale Civile Infermi, Rimini
    Recenti Prog Med 104:80-5. 2013
    ....
  27. ncbi request reprint Staging of breast cancer: new recommended standard procedure
    Alberto Ravaioli
    Department of Medical Oncology and Oncohematology, City Hospital, Rimini, Italy
    Breast Cancer Res Treat 72:53-60. 2002
    ..These procedures are expensive and not all patients need them. We aimed to identify groups of patients with different risks for metastatic disease...
  28. ncbi request reprint Quality of life assessment of randomized controlled trials
    Ilaria Panzini
    Department of Medical Oncology, Infermi Hospital, Rimini, Italy
    Tumori 92:373-8. 2006
    ..This study was performed to review approaches to QOL in randomized controlled clinical trials (RCCTs) and to survey the use of such measures in trials...
  29. ncbi request reprint Malignant pericardial mesothelioma. Report of two cases, review of the literature and differential diagnosis
    Maximilian Papi
    Department of Oncology, Infermi Hospital, Rimini, Italy
    Tumori 91:276-9. 2005
    ..The prognosis is unfavorable. The median survival from the onset of symptoms is six months. In this paper we report two cases of patients with primary mesothelioma of the pericardium without a definite history of asbestos exposure...
  30. ncbi request reprint Treating sialorrhea with transdermal scopolamine. Exploiting a side effect to treat an uncommon symptom in cancer patients
    Davide Tassinari
    Department of Oncology, City Hospital, Rimini, Italy
    Support Care Cancer 13:559-61. 2005
    ..Conversely, it is frequent in patients with neurological damage, and some therapeutic options have been attempted such as botulinum toxins, anticholinergic agents, and surgical procedures...
  31. ncbi request reprint [Preoperative chemotherapy in locally advanced rectal cancer: systematic review of literature]
    Emiliano Tamburini
    Divisione di Oncologia, Ospedale Infermi, IRST, Istituto Scientifico dei Tumori della Romagna, Rimini
    Recenti Prog Med 99:134-40. 2008
    ....
  32. ncbi request reprint Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses
    Ilaria Panzini
    Division of Medical Oncology, Ospedale Infermi, Rimini, Italy
    Tumori 88:21-7. 2002
    ..In this article we re-examine this potential bias, highlighting the differences between the present and past meta-analyses on adjuvant chemotherapy for GC...
  33. doi request reprint High opioid dosage rapid detoxification of cancer patient in palliative care with the Raffaeli model
    Maria Cristina Monterubbianesi
    Pain Therapy and Pallitive Care Unit, Infermi Hospital, Rimini, Italy
    J Opioid Manag 8:292-8. 2012
    ..To overcome this issue, a method of rapid detoxification from opioids has been developed...
  34. ncbi request reprint Carboplatin and gemcitabine in stage IV non small cell lung cancer: beyond cisplatin in palliative chemotherapy
    Davide Tassinari
    Lung Cancer 39:107-8. 2003
  35. ncbi request reprint Surrogate outcomes in quality-of-life research: where will we end up?
    Davide Tassinari
    J Clin Oncol 21:1894-5; author reply 1895. 2003
  36. ncbi request reprint Clinical guidelines in advanced cancer: why we cannot avoid an evidence-based model
    Davide Tassinari
    Tumori 94:622-3. 2008
  37. ncbi request reprint Outcomes of palliative chemotherapy in stage IV non-small cell lung cancer. Have we found what we are looking for?
    Davide Tassinari
    Lung Cancer 43:373-4. 2004
  38. ncbi request reprint A validation study of the WHO analgesic ladder: a two-step vs three-step strategy
    Marco Maltoni
    Palliative Care Unit, Forlimpopoli Hospital, Via Duca d Aosta 33, 47034 Forlimpopoli FC, Italy
    Support Care Cancer 13:888-94. 2005
    ....
  39. ncbi request reprint Target therapies in palliative care: from a clinical to a biological approach
    Davide Tassinari
    J Pain Symptom Manage 28:195-7; author reply 197-8. 2004
  40. ncbi request reprint Quality of care at the end of life: how far are we from reaching a comprehensive solution to the problem?
    Davide Tassinari
    Palliat Med 19:434-5. 2005
  41. ncbi request reprint Prognostic assessment in terminally ill cancer patients: from evidence-based knowledge to a patient-physician relationship and back
    Marco Maltoni
    Palliative Care Unit, Valerio Grassi Hospice, Forlimpopoli FC, Italy
    Palliat Med 18:77-9. 2004
  42. ncbi request reprint Prospective randomized trial of intrapleural bleomycin versus interferon alfa-2b via ultrasound-guided small-bore chest tube in the palliative treatment of malignant pleural effusions
    Sergio Sartori
    Department of Internal Medicine, St Anna Hospital, Ferrara, Italy
    J Clin Oncol 22:1228-33. 2004
    ..To compare bleomycin pleurodesis and immunotherapy with intrapleural interferon alfa-2b (IFN) in the palliation of malignant pleural effusions...
  43. ncbi request reprint Sonographically guided biopsy of bone and soft tissue tumors
    Sergio Sartori
    J Ultrasound Med 21:1056. 2002
  44. ncbi request reprint Can we really consider quality of life as an outcome of palliative care?
    Davide Tassinari
    J Pain Symptom Manage 26:886-7; author reply 888-9. 2003
  45. doi request reprint Central venous catheter-related thrombosis in cancer patients: what we know and what we need to know
    Davide Tassinari
    Support Care Cancer 16:311-2; author reply 313-4. 2008
  46. ncbi request reprint Sonographically guided peritoneal catheter placement in the palliation of malignant ascites in end-stage malignancies
    Sergio Sartori
    Department of Internal Medicine, Section of Interventional Ultrasound, St Anna Hospital, 44100 Ferrara, Italy
    AJR Am J Roentgenol 179:1618-20. 2002
  47. doi request reprint Controversial issues in thromboprophylaxis with low-molecular weight heparins in palliative care
    Davide Tassinari
    J Pain Symptom Manage 36:e3-4. 2008
  48. doi request reprint Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness
    Sergio Sartori
    Department of Internal Medicine, Section of Interventional Ultrasound, St Anna Hospital, Corso Giovecca 203, 44100 Ferrara, Italy
    Radiology 248:670-9. 2008
    ..To assess the safety and effectiveness of percutaneous radiofrequency (RF) ablation of subcapsular liver tumors...